Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors

NCT07404176 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER_GOV

Sponsor class

Conditions

Neuroendocrine Neoplasms (Tumours)
Neuroendocrine Tumors
Metastatic Neuroendocrine Tumors

Interventions

DRUG: Terbium 161

Sponsor

Tata Memorial Hospital